Scientists use gene therapy to shield patients from Chemo's worst side effects in aggressive brain cancer fight
NCT ID NCT05052957
Summary
This trial is testing a new approach for treating a fast-growing brain cancer called glioblastoma. Doctors first collect a patient's own blood stem cells and modify them with a protective gene in the lab. These modified cells are then given back to the patient to help their bone marrow withstand much higher, more effective doses of chemotherapy aimed at killing the remaining cancer cells. The goal is to see if this allows patients to complete the stronger treatment safely and if it helps them live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospitals Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.